136 related articles for article (PubMed ID: 4841377)
1. Post-heparin lipolytic activity and tissue lipoprotein lipase activity in the alloxan-diabetic rat.
Elkeles RS; Williams E
Clin Sci Mol Med; 1974 May; 46(5):661-4. PubMed ID: 4841377
[No Abstract] [Full Text] [Related]
2. Acute diabetes does not reduce heparin-releasable lipoprotein lipase activity in perfused hearts from Wistar-Kyoto rats.
Rodrigues B; Severson DL
Can J Physiol Pharmacol; 1993 Sep; 71(9):657-61. PubMed ID: 8313228
[TBL] [Abstract][Full Text] [Related]
3. Relationship of organ lipoprotein lipase activity and ketonuria to hypertriglyceridemia in starved and streptozocin-induced diabetic rats.
Wilson DE; Zeikus R; Chan IF
Diabetes; 1987 Apr; 36(4):485-90. PubMed ID: 3817303
[TBL] [Abstract][Full Text] [Related]
4. Triglyceride metabolism in the alloxan-diabetic rat.
Brown DF
Diabetes; 1967 Feb; 16(2):90-5. PubMed ID: 6017863
[No Abstract] [Full Text] [Related]
5. Modifications of plasma post-heparin lipolytic activity and tissue lipoprotein lipase activity induced in the rat by acute administration of ethanol or propan-2-ol.
Giudicelli Y; Nordmann R; Nordmann J
Clin Sci Mol Med; 1975 Feb; 48(2):153-6. PubMed ID: 1116333
[TBL] [Abstract][Full Text] [Related]
6. Regulation of lipoprotein lipase activity in cardiac myocytes from control and diabetic rat hearts by plasma lipids.
Rodrigues B; Braun JE; Spooner M; Severson DL
Can J Physiol Pharmacol; 1992 Sep; 70(9):1271-9. PubMed ID: 1493594
[TBL] [Abstract][Full Text] [Related]
7. Effect of tumor necrosis factor (TNF) on lipid metabolism in the diabetic rat. Evidence that inhibition of adipose tissue lipoprotein lipase activity is not required for TNF-induced hyperlipidemia.
Feingold KR; Soued M; Staprans I; Gavin LA; Donahue ME; Huang BJ; Moser AH; Gulli R; Grunfeld C
J Clin Invest; 1989 Apr; 83(4):1116-21. PubMed ID: 2703526
[TBL] [Abstract][Full Text] [Related]
8. Is the hypertriglyceridemia associated with insulin deficiency caused by decreased lipoprotein lipase activity?
Chen YD; Risser TR; Cully M; Reaven GM
Diabetes; 1979 Oct; 28(10):893-8. PubMed ID: 225232
[No Abstract] [Full Text] [Related]
9. Release of clearing factor lipase (lipoprotein lipase) in vivo and from isolated perfused hearts of alloxan diabetic rats.
Aktin E; Meng HC
Diabetes; 1972 Mar; 21(3):149-56. PubMed ID: 5011980
[No Abstract] [Full Text] [Related]
10. On the metabolic function of heparin-releasable liver lipase.
Jansen H; van Tol A; Hülsmann WC
Biochem Biophys Res Commun; 1980 Jan; 92(1):53-9. PubMed ID: 6153525
[No Abstract] [Full Text] [Related]
11. Lipolytic activity of post-heparin plasma & various tissues of mouse.
Sheorain VS; Mattock MB; Subrahmanyam D
Indian J Biochem Biophys; 1977 Mar; 14(1):79-81. PubMed ID: 924492
[No Abstract] [Full Text] [Related]
12. Effects of ethyl-CPIB (clofibrate) on tissue lipoprotein lipase and plasma post-heparin lipolytic activity in rats.
Odonkor JM; Rogers MP
Biochem Pharmacol; 1984 Apr; 33(8):1337-41. PubMed ID: 6370267
[TBL] [Abstract][Full Text] [Related]
13. Effect of experimental hypertriglyceridaemia on tissue and serum lipoprotein lipase activity.
Shafrir E; Biale Y
Eur J Clin Invest; 1970 Mar; 1(1):19-24. PubMed ID: 5470474
[No Abstract] [Full Text] [Related]
14. Dissociation between plasma triglyceride concentration and tissue lipoprotein lipase deficiency in insulin-deficient rats.
Chen YD; Howard J; Huang V; Kraemer FB; Reaven GM
Diabetes; 1980 Aug; 29(8):643-7. PubMed ID: 6449394
[TBL] [Abstract][Full Text] [Related]
15. Response of lipoprotein lipase to calorie intake in streptozotocin-induced diabetic rats.
Inadera H; Tashiro J; Okubo Y; Ishikawa Y; Shirai K; Saito Y; Yoshida S
Scand J Clin Lab Invest; 1992 Dec; 52(8):797-802. PubMed ID: 1283230
[TBL] [Abstract][Full Text] [Related]
16. Studies on lipolytic enzymes in cell culture.
Stein O; Leitersdorf E; Chajek-Shaul T; Friedman G; Stein Y
Monogr Atheroscler; 1986; 14():124-8. PubMed ID: 3736550
[No Abstract] [Full Text] [Related]
17. Regulation of myocardial lipoprotein lipase activity by diabetes and thyroid hormones.
Liu L; Severson DL
Can J Physiol Pharmacol; 1994 Nov; 72(11):1259-64. PubMed ID: 7767864
[TBL] [Abstract][Full Text] [Related]
18. Effect of alloxan-induced chronic diabetes on lipid composition and lipoprotein lipase activity of rat lung.
Pathak RM; Sheorain VS; Khuller GK; Subrahmanyam D
Biochem Med; 1979 Apr; 21(2):215-9. PubMed ID: 465017
[No Abstract] [Full Text] [Related]
19. Cilostazol, a selective type III phosphodiesterase inhibitor, decreases triglyceride and increases HDL cholesterol levels by increasing lipoprotein lipase activity in rats.
Tani T; Uehara K; Sudo T; Marukawa K; Yasuda Y; Kimura Y
Atherosclerosis; 2000 Oct; 152(2):299-305. PubMed ID: 10998457
[TBL] [Abstract][Full Text] [Related]
20. [The influence of glucagon on post-heparin plasma lipolytic activity in normal rats and in rats with diabetes induced by alloxan injection].
Lombardo YB; Cherrier P; Mejean L; Debry G
Biomedicine; 1976 May; 24(2):122-6. PubMed ID: 1276370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
